{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiamuztnxcyvbblmavczou6qjiknagt2mfqhdgihycc5pmaijud3zm",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mqcsxanbcan2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia5v5ud6s2gifvzygtvrkzv7sjqk6r2gnud5bkwox75kwxvp2mb24"
    },
    "mimeType": "image/jpeg",
    "size": 345539
  },
  "path": "/news/2026-07-human-explores-immune-cell-therapy.html",
  "publishedAt": "2026-07-10T14:10:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether immune-engineered, allogeneic insulin-producing cells can survive and function without chronic immunosuppression.",
  "title": "New first-in-human study explores immune-engineered cell therapy approach for type 1 diabetes"
}